Viewing Study NCT02212535


Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2026-02-21 @ 12:18 AM
Study NCT ID: NCT02212535
Status: COMPLETED
Last Update Posted: 2025-09-05
First Post: 2014-08-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessment of Tolerance of Mobilizing Peripheral Hematopoietic Stem Cells by Plerixafor in Sickle Cell Patients
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Major Sickle Cell Syndrome of Type SS or Sβ Thalassemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sickle cell disease View
None Open monocenter study View
None Phase I/II View
None hematopoietic stem cells View
None Plerixafor View